Schroders Unit Trusts has been appointed investment manager and alternative investment fund manager of the International Biotechnology trust (IBT).
The previous investment manager, SV Health Managers, gave a termination notice to the trust in February, with the aim to exit by February 2024, to focus on its core healthcare venture business. The trust's portfolio managers, Ailsa Craig and Marek Poszepczynski, will join Schroders and continue working in their current roles. They have been managing IBT since 2006 and 2013, respectively, and were promoted to joint lead managers in 2021. Investment manager of International Biotech trust gives termination notice Schroders said it has no plans to change the trust's discount and premiu...
To continue reading this article...
Join Investment Week for free
Signup and gain exclusive members-only insights - all free of charge!
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes
